Page Tech Commercialization 101 Tech Commercialization 101 The Polsky Center translates groundbreaking discoveries into real-world impact through licensing, startups, and industry partnerships. Our team evaluates market opportunities, protects intellectual property, secures funding, and develops...
News UChicago Spinout Pyxis Secures $152 Million Series B, Signs Licensing Agreement with Pfizer The University of Chicago spinout Pyxis Oncology has signed a worldwide licensing agreement with Pfizer after raising $152 million to further advance its portfolio of potent biologics. Pyxis in 2019...
Team Han Sun, PhD Assistant Director, Business Development, The Duckworth Family Cancer Fellow Assistant Director, Business Development, The Duckworth Family Cancer Fellow
News Universities Pool Resources, Spotlight Research “The heart of a thriving company-formation effort begins with university research,” said James Tyree, president of Abbott Biotech Ventures and keynote speaker at the Chicago Innovation Spotlight on May 18,...
News Data-driven, Early Intervention Technology for Police Officers Licensed to Benchmark Analytics The University of Chicago announced a partnership with Benchmark Analytics to commercialize an early intervention system for police officers. Benchmark Analytics is a provider of analytics-based police force management and...
Page Weixin Tang // Gene Editing Tools The Tang Lab harnesses the unique properties of nucleic acid-modifying enzymes to profile, edit, and reprogram the human genome and transcriptome. This includes the discovery, characterization, and engineering of CRISPR-derived...
Page License Technologies technology Licensing Discover new solutions to expand your pipeline with breakthrough, validated technologies ready for commercialization. Technologies at the University of Chicago are available for licensing across several industries, from...
News UChicago Supports COVID-19 Research with Non-Exclusive, Royalty-Free License The University of Chicago is committed to supporting the rapid development of new technologies and life-saving therapeutics in the battle against the coronavirus (COVID-19) pandemic. A non-exclusive, royalty-free license will...
Team Kenneth Gayosa Onishi, PhD Senior Manager, Business Development and Licensing - Microbiome Senior Manager, Business Development and Licensing - Microbiome
Team Charlie Shaw, PhD Associate Director, Business Development and Licensing Associate Director, Business Development and Licensing
News Polsky Center Receives $5 Million Gift from Booth Alumnus A gift from David Kessenich, MBA ’96, and his wife, Colleen, will propel new groundbreaking work and faculty-led research at the Polsky Center.
